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Abstract
Apical hypertrophic cardiomyopathy (HCM) is an uncommon variant of HCM characterized
by hypertrophy located in the left ventricular apex that occurs at a rate of about 30% in the
Japanese population.
Although the prognosis of most patients with apical HCM is relatively benign, it can be poor if
apical left ventricular aneurysms develop. However, the mechanism of aneurysmal formation
is unclear. We describe two patients with apical HCM and dissimilar findings in 201Thallous
chloride (201TlCl) and 123I-betamethyl-p-iodophenyl-pentadecanoic acid (123I-BMIPP) dual
single-photon emission computed tomography (dual-SPECT), but no myocardial fibrosis on
contrast-enhanced magnetic resonance images (MRI). One had apparently normal myocardial
perfusion and metabolism, whereas the other had exercise-induced myocardial ischemia and
impaired myocardial metabolism. These findings indicated that even apical HCM without
myocardial fibrosis is pathophysiologically heterogeneous. Apical HCM has been evaluated by
either dual-SPECT or cardiac MRI, but not by both. Thus, a combination of imaging
modalities is apparently essential for elucidating the pathophysiology of apical HCM. These
dissimilar findings in dual-SPECT might be important in identifying patients with apical
HCM who are at high risk of forming aneurysms. (Cardiol J 2010; 17, 3: 306–311)
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Introduction
Apical hypertrophic cardiomyopathy (apical
HCM) is a rare variant of HCM characterized by
localized apical hypertrophy and a giant T-wave in-
version on electrocardiograms [1, 2]. Although the
prognosis of most patients with apical HCM is rel-
atively benign [3], it can be quite poor if the apical
left ventricle contains aneurysms, as they are close-
ly associated with intraventricular thrombosis and
life-threatening arrhythmia [4]. However, the
mechanism of aneurysm formation is unclear.
We describe two patients with apical HCM but
with different findings in 201Thallous chloride
(201TlCl) and 123I-betamethyl-p-iodophenyl-pentade-
canoic acid (123I-BMIPP) dual single-photon emis-
sion computed tomography (dual-SPECT), although
contrast-enhanced magnetic resonance imaging
(MRI) did not identify myocardial fibrosis. We dis-
cuss the potential of combined dual-SPECT and
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contrast-enhanced MRI to evaluate the pathophy-
siology of apical HCM.
Methods
We performed cardiac MRI and dual-SPECT
in two patients who were diagnosed with apical
HCM based on giant T-wave inversions on 12-
-lead rest electrocardiograms and apical hypertro-
phy on transthoracic echocardiograms. Apical hy-
pertrophy was confirmed on magnetic resonance
cine images, and myocardial fibrosis was investi-
gated on gadolinium late enhancement images.
We then performed 201TlCl and 123I-BMIPP dual-
-SPECT to simultaneously evaluate myocardial
perfusion and metabolism. We compared cardiac
MRI and dual-SPECT on arbitrary cross-sectional
images.
Cardiac MRI
Patients underwent cardiac MRI using a 1.5-T
magnetic resonance imaging scanner (Avanto; Sie-
mens, Erlangen, Germany). Cine images were ac-
quired using the segmented ECG-triggered True
FISP sequence [5]. Gadolinium late enhancement
images were acquired using a segmented two-di-
mensional inversion recovery True FISP sequence
about ten minutes after an intravenous injection of
0.15 mmol/kg gadolinium diethylenetriamine pen-
ta-acetic acid (Magnevist; Bayer Schering Pharma
AG, Berlin, Germany) [6].
Dual-SPECT
Within one month of cardiac MRI evaluation,
the patients underwent dual-SPECT evaluation
using a double-headed gamma camera (PRISM-
AXIS, Shimadzu, Kyoto, Japan) after a fast of at least
six hours. A dose of 111 MBq of 123I-BMIPP was
intravenously injected and flushed with 10 mL of
saline at rest. The patient rested for 20 minutes
after the injection to ensure that 123I-BMIPP ade-
quately reflected fatty acid metabolism in the myo-
cardium. Thereafter, an upright bicycle ergometer
exercise test was started according to the ramp in-
cremental protocol. At peak exercise, 111 MBq of
201TlCl was intravenously injected and flushed with
10 mL of saline. The test continued for an addition-
al 60 seconds to allow adequate circulation of the
isotope. Both 201TlCl and 123I-BMIPP-SPECT data
were simultaneously acquired according to the
method of Nishimura et al. [7] within ten minutes
of (early phase) and four hours after (late phase)
exercise completion.
Case 1
A 69 year-old male was admitted to our hospi-
tal with abnormal electrocardiographic findings that
were discovered at a routine health examination.
Hyperlipidemia and hyperuricemia had been treat-
ed with pravastatin sodium and allopurinol respec-
tively. Cardiac symptoms such as chest pain, dysp-
nea, palpitation, faintness and syncope were absent.
A family history of heart disease, sudden death, or
premature death was insignificant. Twelve-lead rest
electrocardiography revealed atrial fibrillation and
giant T-wave inversion in leads II, III, aVF, and V3–
–V6 (Fig. 1, left row), and transthoracic echocardio-
graphy revealed left ventricular apical myocardial
hypertrophy with normal wall motion (Fig. 1, right
row). These findings indicated apical HCM.
He was thus examined by cardiac MRI and
dual-SPECT. Cardiac MRI confirmed the diagnosis
of apical HCM on cine images (Fig. 2A, B), and
showed no hyperintense areas indicating myocar-
dial fibrosis on gadolinium late enhancement imag-
es (Fig. 2C). Next, the dual-SPECT exercise test
was terminated at a heart rate of 120 bpm (100 W)
at the onset of leg fatigue. However, the patient did
not describe any significant cardiac symptoms and
ischemic electrocardiographic changes were absent.
The 201TlCl and 123I-BMIPP images demonstrated
significantly increased uptake in the left ventricu-
lar apical myocardium and no areas of decreased
uptake, indicating impaired myocardial perfusion
and metabolism respectively (Fig. 2D–F). The
above findings indicated a diagnosis of apical HCM
without myocardial fibrosis or impaired myocardial
perfusion and metabolism.
Case 2
A 66 year-old female was referred to our depart-
ment with abnormal electrocardiographic findings at
a pre-operative examination for resection of a uter-
ine leiomyoma. Neither she nor any family member
had a significant history of cardiac conditions and she
was asymptomatic for cardiac diseases. Twelve-lead
rest electrocardiography showed giant T-wave inver-
sion in leads I, II, aVl, and V3–V6 (Fig. 3, left row),
and transthoracic echocardiography revealed left
ventricular apical myocardial hypertrophy with nor-
mal wall motion (Fig. 3, right row), indicating apical
HCM. Cardiac MRI confirmed apical HCM on cine
images (Fig. 4A, B), and showed no hyperintense
areas on gadolinium late enhancement images (Fig. 4C).
A dual-SPECT exercise test was terminated at
a heart rate of 100 bpm (80 W) at the onset of leg
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Figure 1. Electrocardiogram (left row) shows atrial fibrillation and giant T-wave inversion in leads II, III, aVF, and V3–V6.
Transthoracic echocardiography (right row) at diastole (A) and at systole (B) reveals left ventricular apical myocardial
hypertrophy with normal wall motion in the apical two-chamber view (arrows).
Figure 2. Cardiac magnetic resonance imaging cine imaging at diastole (A) and at systole (B) confirms left ventricular
apical myocardial hypertrophy with normal wall motion (arrowheads). Gadolinium late enhancement imaging (C)
shows no hyperintense areas. 201TlCl images at early (D) and late (E) phases and 123I-BMIPP image (F) show significan-
tly increased uptake in left ventricular apical myocardium (arrows).
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fatigue, after which the patient did not describe any
significant cardiac symptoms. No ischemic electro-
cardiographic changes were evident. The 201TlCl
images demonstrated a significantly decreased up-
take area in the left ventricular apical myocardium
during the early phase (Fig. 4D) and complete re-
distribution at the late phase (Fig. 4E), indicating
exercise-induced myocardial ischemia. The 123I-
-BMIPP images also demonstrated a significantly
decreased uptake area in the apical myocardium dur-
ing the early phase (Fig. 4F), indicating myocardial
metabolism impaired by a microcirculatory disorder
or delayed recovery from impaired myocardial me-
tabolism induced by past ischemia.
However, the decreased uptake area on 123I-
-BMIPP images was consistent with the exercise-
induced ischemic myocardial area identified by
201TlCl-SPECT. We thus considered that these find-
ings reflected delayed recovery from impaired myo-
cardial metabolism induced by past exercise-in-
duced ischemia. Coronary computed tomography
angiography confirmed the absence of significant
coronary stenosis. These findings indicated a diag-
nosis of apical HCM with exercise-induced myocar-
dial ischemia and impaired myocardial metabolism,
but no myocardial fibrosis.
Discussion
Dual 201TlCl and 123I-BMIPP SPECT has been
widely applied in Europe and Japan to evaluate pa-
tients with various types of heart disease. Myocar-
dial perfusion is usually evaluated by 201TlCl, where-
as 123I-BMIPP reflects fatty acid metabolism in the
heart.  A decrease in 123I-BMIPP accumulation in-
dicates myocardial areas where fatty acid metabo-
lism is suppressed and the source of ATP produc-
tion switches from fatty acid to glucose because of
current and past ischemia as well as microcircu-
latory disorders [8]. Moreover, a reduction in
BMIPP is the most sensitive indicator of metabolic
abnormalities in patients with HCM [9].
Thus, dual-SPECT can simultaneously evalu-
ate both myocardial perfusion and metabolism,
whereas cardiac MRI is one of the most rigorous
and accurate methods of evaluating cardiac mor-
phology and fibrosis. Comparisons are facilitated
because both dual-SPECT and cardiac MRI can pro-
vide several arbitrary cross-sectional images of the
heart.
Here, dual-SPECT classified two apical HCM
patients without myocardial fibrosis in contrast-
enhanced MRI into subtypes with and without im-
Figure 3. Electrocardiogram (left row) shows giant T-wave inversion in leads I, II, aVl, and V3–V6. Transthoracic
echocardiography (right row) at diastole (A) and at systole (B) reveals left ventricular apical myocardial hypertrophy
with normal wall motion in the apical two-chamber view (arrows).
310
Cardiology Journal 2010, Vol. 17, No. 3
www.cardiologyjournal.org
Figure 4. Cardiac magnetic resonance imaging cine images at diastole (A) and at systole (B) confirm left ventricular
apical myocardial hypertrophy with normal wall motion (solid arrowheads). Gadolinium late enhancement image (C)
shows no hyperintense areas. 201TlCl image at early phase (D) shows area of significantly decreased uptake in left
ventricular apical myocardium, and 201TlCl image at late phase (E) shows complete redistribution (solid arrows).
123I-BMIPP image at early phase (F) shows area of significantly decreased uptake in apical myocardium (unfilled
arrows).
paired myocardial perfusion (exercise-induced myo-
cardial ischemia) and metabolism. These findings
indicated that even apical HCM without myocardial
fibrosis is pathophysiologically heterogeneous.
Because the presence of myocardial fibrosis is re-
lated to cardiac dysfunction and arrhythmia in HCM,
its absence is associated with a relatively benign
prognosis [10, 11]. However, even without myocar-
dial fibrosis in contrast-enhanced MRI, the long-
-term prognosis of patients with impaired myocar-
dial ischemia and metabolism according to dual-
-SPECT is considered to be poor. This is because
apical mismatch areas with impaired myocardial
perfusion and metabolism, but no myocardial fibro-
sis, can probably predict the development of new
myocardial fibrosis, and it might be longitudinally
associated with the formation of apical aneurysms.
Apical HCM has been evaluated by either dual-
-SPECT [12] or cardiac MRI alone [13], but not by
both. These cases suggest that the combination of
imaging modalities is essential for elucidating the
pathophysiology of apical HCM.
In conclusion, Dual-SPECT uncovered dissim-
ilar myocardial perfusion and metabolism between
two patients who had apical HCM without myocar-
dial fibrosis on contrast-enhanced MRI. This combi-
nation of imaging modalities should thus help to cla-
rify the pathophysiology of patients with apical HCM.
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